Your browser doesn't support javascript.
loading
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.
Deveson, Ira W; Gong, Binsheng; Lai, Kevin; LoCoco, Jennifer S; Richmond, Todd A; Schageman, Jeoffrey; Zhang, Zhihong; Novoradovskaya, Natalia; Willey, James C; Jones, Wendell; Kusko, Rebecca; Chen, Guangchun; Madala, Bindu Swapna; Blackburn, James; Stevanovski, Igor; Bhandari, Ambica; Close, Devin; Conroy, Jeffrey; Hubank, Michael; Marella, Narasimha; Mieczkowski, Piotr A; Qiu, Fujun; Sebra, Robert; Stetson, Daniel; Sun, Lihyun; Szankasi, Philippe; Tan, Haowen; Tang, Lin-Ya; Arib, Hanane; Best, Hunter; Burgher, Blake; Bushel, Pierre R; Casey, Fergal; Cawley, Simon; Chang, Chia-Jung; Choi, Jonathan; Dinis, Jorge; Duncan, Daniel; Eterovic, Agda Karina; Feng, Liang; Ghosal, Abhisek; Giorda, Kristina; Glenn, Sean; Happe, Scott; Haseley, Nathan; Horvath, Kyle; Hung, Li-Yuan; Jarosz, Mirna; Kushwaha, Garima; Li, Dan.
Afiliação
  • Deveson IW; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Gong B; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Lai K; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
  • LoCoco JS; Bioinformatics, Integrated DNA Technologies, Inc., Coralville, IA, USA.
  • Richmond TA; Illumina, Inc., San Diego, CA, USA.
  • Schageman J; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA.
  • Zhang Z; Clinical Sequencing Division, Thermo Fisher Scientific, Austin, TX, USA.
  • Novoradovskaya N; Research and Development, Burning Rock Biotech, Shanghai, China.
  • Willey JC; Agilent Technologies, La Jolla, CA, USA.
  • Jones W; Departments of Medicine, Pathology, and Cancer Biology, College of Medicine and Life Sciences, University of Toledo Health Sciences Campus, Toledo, OH, USA.
  • Kusko R; Q2 Solutions - EA Genomics, Morrisville, NC, USA.
  • Chen G; Immuneering Corporation, Cambridge, MA, USA.
  • Madala BS; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Blackburn J; Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Stevanovski I; Cancer Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Bhandari A; St. Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Close D; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Conroy J; ResearchDx, Inc., Irvine, CA, USA.
  • Hubank M; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA.
  • Marella N; OmniSeq, Inc., Buffalo, NY, USA.
  • Mieczkowski PA; NIHR Biomedical Research Centre, Royal Marsden Hospital, Sutton, Surrey, UK.
  • Qiu F; Cancer Genetics, Inc., Rutherford, NJ, USA.
  • Sebra R; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
  • Stetson D; Research and Development, Burning Rock Biotech, Shanghai, China.
  • Sun L; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Szankasi P; Astrazeneca Pharmaceuticals, Waltham, MA, USA.
  • Tan H; Elim Biopharmaceuticals, Inc., Hayward, CA, USA.
  • Tang LY; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA.
  • Arib H; Primbio Genes Biotechnology, East Lake High-tech Development Zone, Wuhan, Hubei, China.
  • Best H; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA.
  • Burgher B; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bushel PR; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA.
  • Casey F; Departments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Cawley S; OmniSeq, Inc., Buffalo, NY, USA.
  • Chang CJ; National Institute of Environmental Health Sciences, Research Triangle Park, Morrisville, NC, USA.
  • Choi J; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA.
  • Dinis J; Clinical Sequencing Division, Thermo Fisher Scientific, South San Francisco, CA, USA.
  • Duncan D; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA.
  • Eterovic AK; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA.
  • Feng L; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA.
  • Ghosal A; Cancer Genetics, Inc., Rutherford, NJ, USA.
  • Giorda K; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA.
  • Glenn S; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA.
  • Happe S; ResearchDx, Inc., Irvine, CA, USA.
  • Haseley N; Marketing, Integrated DNA Technologies, Inc., Coralville, IA, USA.
  • Horvath K; OmniSeq, Inc., Buffalo, NY, USA.
  • Hung LY; Agilent Technologies, Cedar Creek, TX, USA.
  • Jarosz M; Illumina, Inc., San Diego, CA, USA.
  • Kushwaha G; ResearchDx, Inc., Irvine, CA, USA.
  • Li D; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Nat Biotechnol ; 39(9): 1115-1128, 2021 09.
Article em En | MEDLINE | ID: mdl-33846644
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência de DNA / Medicina de Precisão / DNA Tumoral Circulante / Oncologia / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência de DNA / Medicina de Precisão / DNA Tumoral Circulante / Oncologia / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article